首页|肥厚型心肌病合并心房颤动非药物治疗研究进展

肥厚型心肌病合并心房颤动非药物治疗研究进展

扫码查看
心房颤动(房颤)是肥厚型心肌病(HCM)常合并的心律失常,HCM舒张功能障碍、心房纤维化、遗传基因、血流动力学等相关因素促进房颤发生,房颤亦可加重HCM进展。目前HCM合并房颤的非药物治疗包括手术间隔肌切除、酒精室间隔消融、导管消融、双腔起搏器植入等,随着诊疗手段的不断更新仍有很多突破的可能。现就HCM合并房颤的非药物治疗展开综述。
Non-Pharmacological Treatment of Hypertrophic Cardiomyopathy Complicated with Atrial Fibrillation
Atrial fibrillation(AF)is a common arrhythmia associated with hypertrophic cardiomyopathy(HCM).Factors such as impaired diastolic function,atrial fibrosis,genetic inheritance,and hemodynamic changes contribute to the occurrence of AF,which can also worsen the progression of HCM.Non-pharmacological treatment for HCM with AF currently include surgical septal myectomy,alcohol septal ablation,catheter ablation,and dual-chamber pacemaker implantation.As diagnostic and therapeutic methods continue to advance,there is still potential for many breakthroughs in the non-pharmacological treatment of HCM with AF.This review will focus on the non-pharmacological treatment of HCM with AF.

Hypertrophic cardiomyopathyAtrial fibrillationTreatmentAblationSeptal myectomy

余淼、汤宝鹏

展开 >

新疆医科大学第一附属医院心脏起搏电生理科,新疆乌鲁木齐 830054

肥厚型心肌病 心房颤动 治疗 消融 间隔肌切除

国家自然科学基金国家自然科学基金

8237032682260065

2024

心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
年,卷(期):2024.45(1)
  • 27